| Title: | Chromos Molecular Systems Inc. (CHR:CA): Drug/Medical Device |
| Price: | $70.00 |
| Publication Date: | Jul 28, 2007 |
| Company: | Chromos Molecular Systems Inc. |
| Report Type: | Drug/Medical Device Report |
| Abstract: | The most complete and accurate coverage of a company's FDA approved products and pipeline candidates. |
| Brief Excerpt: | ...This report examines the Drug/Medical Device pipeline of Chromos Molecular Systems Inc. (CHR:CA), detailing each drug/device's indication, clinical trial status, and mechanism of action. Furthermore, this report identifies the Focus Sector of Chromos Molecular Systems Inc. (CHR:CA), and analyzes its pipeline and performance against the Focus Sector to which it belongs. In summary, this Drug/Medical Device Report makes available # key pieces of data that help determine the performance and risk of Biotech, Pharmaceutical and Medical Device companies: (#) product/candidate pipeline, (#) product/candidate clinical trial status, and (#) product/candidate pipeline diversification. ... |
| Word Count: | 726 |
| Length: | 5 Pages |
| Ticker: | ?321512 |
| Exchange: | TSX |
| Country: | Canada |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
